Latest stories on ATHE
Alterity Therapeutics Releases Appendix 4C – Q4 FY26 Quarterly Cash Flow Report & Corporate Update
Business Insider59 · neutralproduct/pr
Alterity Therapeutics to Participate in the Virtual BTIG Biotechnology Conference 2026 | ATHE Stock News
StockTitan56 · neutralproduct/pr
Alterity Therapeutics Files June 2026 Form 6-K Highlighting Changes in Directors’ Interests
TipRanks50 · neutralgeneral
Alterity Therapeutics Files June 2026 Corporate Presentation With U.S. Regulator
TipRanks50 · neutralgeneral
Alterity Therapeutics Files June Form 6-K Highlighting Cessation of Certain Securities
TipRanks48 · neutralgeneral
Alterity, FDA agree on phase 3 program for multiple system atrophy asset ATH434
Seeking Alpha67 · bullishgeneral